<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Urinalysis in the diagnosis of kidney disease</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Urinalysis in the diagnosis of kidney disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Urinalysis in the diagnosis of kidney disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ron Wald, MDCM, MPH, FRCPC</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gary C Curhan, MD, ScD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Albert Q Lam, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 20, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3969070652"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The urinalysis is an informative and noninvasive diagnostic tool that is readily accessible to the clinician in both the ambulatory and hospital settings. In conjunction with the history, physical examination, and laboratory testing, the urinalysis plays a central role in evaluating acute and chronic kidney disease. In addition, abnormal findings on a routine urinalysis, even in an otherwise asymptomatic patient, may be the first evidence of underlying kidney disease. The urinalysis can also be used in some patients to monitor the course of established kidney disease.</p><p>Interpretation of the urinalysis in patients with established or suspected kidney disease will be presented in this topic. Assessment of kidney function, a general approach to the patient with kidney disease, an overview of the indications for kidney biopsy, and the differential diagnosis and evaluation of glomerular disease are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2359.html" rel="external">"Assessment of kidney function"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7188.html" rel="external">"Diagnostic approach to adult patients with subacute kidney injury in an outpatient setting"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3067.html" rel="external">"The kidney biopsy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3041.html" rel="external">"Glomerular disease: Evaluation and differential diagnosis in adults"</a>.)</p><p></p><p class="headingAnchor" id="H2557347368"><span class="h1">GENERAL PRINCIPLES</span></p><p class="headingAnchor" id="H3496515220"><span class="h2">Components of the urinalysis</span><span class="headingEndMark"> — </span>A complete urinalysis consists of three components:</p><p class="bulletIndent1"><span class="glyph">●</span>Gross assessment of the urine (see <a class="local">'Gross assessment of the urine'</a> below)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Urine dipstick analysis (see <a class="local">'Urine dipstick analysis'</a> below)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Microscopic examination of the urinary sediment (see <a class="local">'Examination of the urine sediment'</a> below)</p><p></p><p class="headingAnchor" id="H3195944876"><span class="h2">Indications for testing</span></p><p class="headingAnchor" id="H654808207"><span class="h3">When to perform a urinalysis</span><span class="headingEndMark"> — </span>A urinalysis may provide diagnostic insight in the following settings:</p><p class="bulletIndent1"><span class="glyph">●</span>In a patient with an acute or chronic reduction in the glomerular filtration rate or unexplained albuminuria.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a patient with suspected kidney disease. Kidney disease may be suspected on the basis of clinical findings (eg, edema) or because of a concurrent illness or condition that is commonly associated with kidney disease (eg, systemic lupus erythematosus, small-vessel vasculitis, newly identified hypertension).</p><p></p><p class="headingAnchor" id="H30923942"><span class="h3">When to examine the urine sediment</span><span class="headingEndMark"> — </span>Microscopic examination of the urine sediment <strong>should be performed</strong> in the following settings:</p><p class="bulletIndent1"><span class="glyph">●</span>In all patients with acute kidney injury (AKI), with the possible exception of those with ultrasonographically proven kidney obstruction</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the initial workup of most patients with undifferentiated chronic kidney disease (CKD)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In an otherwise asymptomatic patient in order to clarify the significance of findings noted on urine dipstick analyses (eg, microscopic hematuria) when the dipstick was part of a workup for another condition (eg, hypertension, diabetes mellitus, connective tissue disease)</p><p></p><p>Microscopic examination of the urine may be helpful in the following settings:</p><p class="bulletIndent1"><span class="glyph">●</span>The serial follow-up of acute and chronic kidney diseases</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The initial evaluation of patients with kidney stones (see  <a class="medical medical_review" href="/d/html/7377.html" rel="external">"Kidney stones in adults: Evaluation of the patient with established stone disease", section on 'Urinalysis'</a>)</p><p></p><p>Microscopic examination of the urine may <strong>not </strong>be needed in the following settings:</p><p class="bulletIndent1"><span class="glyph">●</span>In patients with mildly to moderately impaired kidney function (estimated glomerular filtration rate 30 to 59 mL/min/1.73 m<sup>2</sup>) and no abnormalities on urine dipstick (eg, hematuria, albuminuria)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with diabetes who have reduced kidney function and albuminuria but no other abnormalities on urine dipstick (eg, hematuria)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with symptoms suggestive of urinary tract infection and concomitant positive testing for leukocyte esterase and/or nitrite on urine dipstick</p><p></p><p class="headingAnchor" id="H1472868847"><span class="h2">Specimen collection</span><span class="headingEndMark"> — </span>The urine specimen must be properly collected in order to reliably interpret the findings and therefore maximize diagnostic utility. The following technique should be followed whenever feasible [<a href="#rid1">1</a>]:</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The specimen should be collected into a clean, dry container.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients should be asked to clean the external genitalia and provide a midstream specimen for analysis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with indwelling urinary catheters, a sample should be obtained directly from the catheter tubing, rather than from the urometer or drainage bag. This will ensure that the sample represents recently produced urine and avoids contamination by debris in the collection bag.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The specimen should be examined at room temperature within two hours of retrieval. If this is not feasible, the sample should be refrigerated at 2 to 8°C and then re-warmed to room temperature prior to assessment. Clinicians should be aware that this approach may lead to the detection of crystals that precipitate at cooler temperatures but do not dissolve in solution upon re-warming.</p><p></p><p class="headingAnchor" id="H2276507849"><span class="h1">GROSS ASSESSMENT OF THE URINE</span><span class="headingEndMark"> — </span>Normal urine is clear and light yellow in color. Urine turbidity and color may be altered in a number of settings.</p><p class="headingAnchor" id="H4223609873"><span class="h2">Urine color</span><span class="headingEndMark"> — </span>The typical yellow color of urine is lighter when urine is dilute and darker when concentrated, such as after an overnight water restriction. The urine may also have a variety of other colors.</p><p class="headingAnchor" id="H2641063697"><span class="h3">Red to brown urine</span><span class="headingEndMark"> — </span>The excretion of red to brown urine is observed in a variety of settings [<a href="#rid2">2</a>]. The initial step in the evaluation of this abnormality is centrifugation of the urine to see whether the red color is in the urine sediment or the supernatant  (<a class="graphic graphic_algorithm graphicRef55923" href="/d/graphic/55923.html" rel="external">algorithm 1</a>).</p><p class="bulletIndent1"><span class="glyph">●</span>If the red color is seen only in the sediment (and the supernatant is not red), the patient likely has hematuria. (See <a class="local">'Heme'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If, on the other hand, the supernatant is red, then the supernatant should be tested for heme (frequently labeled as "blood") with a urine dipstick:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If a urine dipstick of the red supernatant is positive for heme, the patient has either hemoglobinuria or myoglobinuria. (See <a class="local">'Hemoglobinuria and myoglobinuria'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If a urine dipstick of the red supernatant is negative for heme, one of the following conditions should be considered:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Use of certain medications such as <a class="drug drug_general" data-topicid="9864" href="/d/drug information/9864.html" rel="external">rifampin</a>, <a class="drug drug_general" data-topicid="9769" href="/d/drug information/9769.html" rel="external">phenytoin</a>, or hydroxycobalamin </p><p class="bulletIndent3"><span class="glyph">-</span>Consumption of food dyes</p><p class="bulletIndent3"><span class="glyph">-</span>Ingestion of beets (beeturia), rhubarb, or <a class="drug drug_general" data-topicid="10260" href="/d/drug information/10260.html" rel="external">senna</a></p><p class="bulletIndent3"><span class="glyph">-</span>Acute intermittent porphyria</p><p></p><p class="headingAnchor" id="H429701789"><span class="h4">Hemoglobinuria and myoglobinuria</span><span class="headingEndMark"> — </span>Hemoglobinuria is the presence of free hemoglobin (which is normally only present inside intact red blood cells [RBCs]) in the urine. This may occur during episodes of intravascular hemolysis or lysis of RBCs in the urine. Myoglobinuria is the presence of free myoglobin (which is normally only present in intact muscle cells) in the urine. This may occur during rhabdomyolysis (eg, due to crush injury of muscle). Both hemoglobinuria and myoglobinuria can produce a red or red to brown urine:</p><p class="bulletIndent1"><span class="glyph">●</span>Hemoglobin is relatively poorly filtered due both to its large size (molecular weight 69,000 of the tetramer and 34,000 of the dimer) and protein binding to haptoglobin. Only the unbound dimer is filtered. Hemoglobinuria will not occur until haptoglobin is fully saturated and the filtered load of free hemoglobin exceeds proximal reabsorptive capacity.</p><p></p><p class="bulletIndent1">Hemoglobinuria is often associated with red urine. However, the combination of prolonged transit time through the nephron with glomerular bleeding and an acid urine pH may result in the formation of methemoglobin, which has a smoky brown or "Coca cola" color [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/d/html/7208.html" rel="external">"Etiology and evaluation of hematuria in adults", section on 'Glomerular versus nonglomerular bleeding'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Myoglobin, by comparison, is a monomer (molecular weight 17,000) and is not protein bound. As a result, it is rapidly filtered and excreted, thereby allowing the plasma to retain its normal color unless kidney failure limits its excretion. The source of the excess myoglobin is skeletal muscle breakdown (rhabdomyolysis), which is also associated with a marked elevation in the serum creatine kinase concentration.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/5169.html" rel="external">"Rhabdomyolysis: Clinical manifestations and diagnosis", section on 'Urine findings and myoglobinuria'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/14034.html" rel="external">"Clinical features and diagnosis of heme pigment-induced acute kidney injury", section on 'Urinalysis'</a>.)</p><p></p><p class="headingAnchor" id="H1379122933"><span class="h3">Other urine colors</span><span class="headingEndMark"> — </span>Rarely, the urine has other colors, including:</p><p class="bulletIndent1"><span class="glyph">●</span>White urine, which may be due to phosphate crystals, chyluria [<a href="#rid4">4,5</a>], or <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pink urine, presumably due to uric acid crystals, which may occur following <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> administration [<a href="#rid7">7-9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Green urine, which may be due to the administration of <a class="drug drug_general" data-topicid="9636" href="/d/drug information/9636.html" rel="external">methylene blue</a> [<a href="#rid10">10</a>], <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> [<a href="#rid11">11-15</a>], <a class="drug drug_general" data-topicid="8605" href="/d/drug information/8605.html" rel="external">amitriptyline</a>, or rarely, from urinary tract infection caused by <em>Pseudomonas aeruginosa</em> [<a href="#rid16">16,17</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Black urine, which may be due to hemoglobinuria [<a href="#rid18">18,19</a>], myoglobulinuria, melanuria in the context of metastatic melanoma [<a href="#rid20">20</a>], or ochronosis. The black urine in ochronosis, which usually results from alkaptonuria (also called "black urine disease"), is caused by the urinary excretion of homogentisic acid. The black color may only be apparent after the urine stands for some time, permitting the oxidation of homogentisic acid. (See  <a class="medical medical_review" href="/d/html/2935.html" rel="external">"Disorders of tyrosine metabolism", section on 'Alkaptonuria'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Purple urine, which may be due to bacteriuria in patients with urinary catheters [<a href="#rid21">21,22</a>], or coadministration of <a class="drug drug_general" data-topicid="9636" href="/d/drug information/9636.html" rel="external">methylene blue</a> and hydroxycobalamin [<a href="#rid23">23</a>]. (See  <a class="medical medical_review" href="/d/html/8054.html" rel="external">"Catheter-associated urinary tract infection in adults", section on 'Pathogenesis'</a>.)  </p><p></p><p class="headingAnchor" id="H1004708462"><span class="h2">Turbidity</span><span class="headingEndMark"> — </span>Normal urine is usually clear. Turbid urine may be seen in the setting of infection, or as a result of precipitated crystals or chyluria [<a href="#rid24">24</a>]. Contamination caused by genital secretions may also cause turbid urine.</p><p class="headingAnchor" id="H1971017989"><span class="h2">Urine odor</span><span class="headingEndMark"> — </span>An abnormal pungent odor of the urine is most frequently caused by the production of ammonia by bacteria. The presence of ketones in the urine may cause the urine to have a sweet or fruity odor. Certain rare disorders are associated with specific odors to the urine:</p><p class="bulletIndent1"><span class="glyph">●</span>Maple syrup urine disease, which can confer a maple syrup odor to the urine (see  <a class="medical medical_review" href="/d/html/2922.html" rel="external">"Overview of maple syrup urine disease"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Phenylketonuria, which can confer a musty or mousy odor to the urine (see  <a class="medical medical_review" href="/d/html/2919.html" rel="external">"Overview of phenylketonuria"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Isovaleric acidemia, which can confer a sweaty feet odor to the urine (see  <a class="medical medical_review" href="/d/html/2927.html" rel="external">"Organic acidemias: An overview and specific defects", section on 'Isovaleric acidemia'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypermethioninemia, which can confer a rancid butter or fishy odor to the urine</p><p></p><p class="headingAnchor" id="H2536300042"><span class="h1">URINE DIPSTICK ANALYSIS</span><span class="headingEndMark"> — </span>The urine dipstick provides a rapid semiquantitative assessment of urinary characteristics on a series of colorimetric pads embedded on a test strip. Most urine dipsticks permit the analysis of the following core parameters: specific gravity, pH, heme, leukocyte esterase, nitrite, albumin, and glucose. Some dipsticks include test pads for additional parameters including urobilinogen and ketones, although these are generally not used in the diagnosis of kidney disease. Users should be familiar with the specific characteristics of the reagent strips they are using and adhere to manufacturer instructions regarding the amount of urine required and the time that needs to elapse before interpreting the color on any given test pad.</p><p class="headingAnchor" id="H3843413242"><span class="h2">Specific gravity</span><span class="headingEndMark"> — </span>The osmolality of the urine can be inferred by measuring the urine specific gravity, which is defined as the weight of the solution compared with the weight of an equal volume of distilled water. The urine specific gravity generally varies with the osmolality, rising by approximately 0.001 for every 35 to 40 mosmol/kg increase in urine osmolality  (<a class="graphic graphic_figure graphicRef75070" href="/d/graphic/75070.html" rel="external">figure 1</a>). Thus, a urine osmolality of 280 mosmol/kg (which is isosmotic to normal plasma, or "isosthenuric") is usually associated with a urine specific gravity of 1.008 or 1.009.</p><p>However, there is an important difference between these measures: The urine osmolality is determined by the number of particles in the urine (eg, urea, sodium, potassium), while the specific gravity is determined by both the number and size of the particles in the urine. This becomes important clinically when there are large molecules in the urine, such as glucose or radiocontrast media. In these settings, the specific gravity can exceed 1.030 (suggesting a highly concentrated urine) despite a urine osmolality that may be isosmotic or dilute relative to plasma.</p><p>By contrast, there are no causes of a falsely low urine specific gravity. A specific gravity ≤1.003 is indicative of a maximally dilute urine (≤100 mosmol/kg).</p><p class="headingAnchor" id="H2570756878"><span class="h2">pH</span><span class="headingEndMark"> — </span>The urine hydrogen ion concentration, expressed as the pH, reflects the degree of acidification of the urine. The physiologic urine pH ranges from 4.5 to 8, depending upon the systemic acid-base balance. The urine pH is most often used clinically in patients with metabolic acidosis. The appropriate kidney response to acidemia is to increase urinary acid excretion, with the urine pH falling below 5. A higher value suggests the presence of renal tubular acidosis. A discussion of the urine pH in the diagnosis of renal tubular acidosis is presented elsewhere. (See  <a class="medical medical_review" href="/d/html/2327.html" rel="external">"Overview and pathophysiology of renal tubular acidosis and the effect on potassium balance"</a>.)</p><p>In some settings, the urine pH is not indicative of acid excretion by the kidneys. As an example, infection with any pathogen that produces urease, such as <em>Proteus mirabilis</em>, can result in a urine pH above 8, even if urinary acidification is normal.</p><p class="headingAnchor" id="H449820954"><span class="h2">Heme</span><span class="headingEndMark"> — </span>Heme acts as a pseudoperoxidase, and when heme-containing urine is exposed to peroxide and a chromogen on the test pad, a color change takes place [<a href="#rid25">25</a>]. However, a positive dipstick for heme may result not only from urinary red blood cells (RBCs) but also from free hemoglobin or free myoglobin. In addition, the dipstick may be falsely positive if there is semen present in the urine [<a href="#rid26">26</a>]. Thus, a positive dipstick does not establish the presence of RBCs in the urine, and the diagnosis of hematuria requires confirmation with microscopy [<a href="#rid27">27</a>]. (See <a class="local">'Hemoglobinuria and myoglobinuria'</a> above and  <a class="medical medical_review" href="/d/html/7208.html" rel="external">"Etiology and evaluation of hematuria in adults"</a>.)</p><p>The detection of heme by urine dipstick is thought of as a highly sensitive test for the presence of RBCs equivalent to 1 to 2 RBCs per high-powered field [<a href="#rid28">28</a>]. False-negative results are said to be unusual, and as a result, a dipstick that is negative for heme theoretically excludes the presence of RBCs [<a href="#rid29">29,30</a>]. In theory, however, urinary ascorbic acid can interfere with the peroxidase reaction, thereby yielding false-negative results [<a href="#rid31">31</a>]. Given the prevalence of vitamin C ingestion, this may limit the value of the urine dipstick as a screening test for hematuria. Dipstick manufacturers have attempted to allay such concerns through the production of dipsticks that oxidize ascorbic acid, thereby minimizing the risk of false negatives [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H3460275911"><span class="h2">Leukocyte esterase</span><span class="headingEndMark"> — </span>Leukocyte esterase released by lysed neutrophils and macrophages is a marker for the presence of white blood cells (WBCs). However, a concentrated urine may impede cell lysis and therefore produce a false-negative result. Proteinuria and glucosuria may also lead to a false-negative test for leukocyte esterase [<a href="#rid25">25</a>].</p><p class="headingAnchor" id="H2512631518"><span class="h2">Nitrite</span><span class="headingEndMark"> — </span>Many <em>Enterobacteriaceae </em>species, the most common microorganisms causing urinary tract infections, elaborate the enzyme nitrate reductase, which converts urinary nitrate to nitrite. Thus, nitrite-positive urine may indicate underlying bacteriuria. By contrast, urinary infections with enterococcal species, which express low levels of nitrate reductase, may test negative for nitrites [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H4008071924"><span class="h2">Protein</span><span class="headingEndMark"> — </span>The urine dipstick test for protein is most sensitive to albumin and provides a semiquantitative means of assessing albuminuria. The dipstick is <strong>insensitive</strong> to non-albumin proteins, most notably immunoglobulin light chains.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Albuminuria</strong> – There are several important limitations of dipstick testing for albuminuria:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Moderately increased albuminuria in the range of 30 to 300 mg/day (formerly called "microalbuminuria") may be below the limit of detection of the urine dipstick, particularly if the urine is dilute. (See  <a class="medical medical_review" href="/d/html/3101.html" rel="external">"Assessment of urinary protein excretion and evaluation of isolated non-nephrotic proteinuria in adults", section on 'Amounts of proteinuria'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Severely increased albuminuria (more than 300 mg/day, formerly called "macroalbuminuria") may be undetectable or underestimated if the urine is very dilute.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The semiquantitative categories of albuminuria that are reported (eg, trace, 1+, 2+, and 3+) may be misleading. A dilute urine, for example, will underestimate the degree of albuminuria. By contrast, a concentrated urine may register as 3+ but may <strong>not</strong> indicate high-grade albuminuria.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Recent exposure to iodinated radiocontrast agents can induce transient albuminuria [<a href="#rid33">33</a>]. However, this may not be observed with newer non-ionic contrast agents [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent1">A patient with a persistently positive dipstick test for protein should have albuminuria quantified with assessment of the albumin-to-creatinine ratio on a random (spot) urine sample or with a 24-hour urine collection. (See  <a class="medical medical_patient" href="/d/html/2181.html" rel="external">"Patient education: Collection of a 24-hour urine specimen (Beyond the Basics)"</a> and  <a class="medical medical_review" href="/d/html/3101.html" rel="external">"Assessment of urinary protein excretion and evaluation of isolated non-nephrotic proteinuria in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Non-albumin proteinuria</strong> – The dipstick is not sensitive to non-albumin proteins, such as immunoglobulin light chains. A screen for the presence of such proteins may be performed with the sulfosalicylic acid (SSA) test.</p><p></p><p class="bulletIndent1">SSA detects all proteins in urine and may be useful in patients with acute kidney injury (AKI) of unclear etiology and a urine dipstick that is negative for protein. A positive SSA test in conjunction with a negative dipstick usually indicates the presence of non-albumin proteins in the urine, most often immunoglobulin light chains. (See  <a class="medical medical_review" href="/d/html/7210.html" rel="external">"Kidney disease in multiple myeloma and other monoclonal gammopathies: Etiology and evaluation"</a>.)</p><p></p><p class="bulletIndent1">The SSA test is performed by mixing 1 part urine supernatant with 3 parts 3 percent SSA and assessing whether the urine becomes turbid, which suggests the presence of proteinuria. The SSA test is described in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/3101.html" rel="external">"Assessment of urinary protein excretion and evaluation of isolated non-nephrotic proteinuria in adults", section on 'Sulfosalicylic acid test'</a>.)</p><p></p><p>The clinical significance of dipstick proteinuria has been demonstrated in multiple settings [<a href="#rid35">35,36</a>], and the presence and degree of proteinuria have become a fundamental part of chronic kidney disease (CKD) staging [<a href="#rid37">37</a>] and the prognostication of progression [<a href="#rid38">38,39</a>]. This issue is discussed in detail elsewhere:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3101.html" rel="external">"Assessment of urinary protein excretion and evaluation of isolated non-nephrotic proteinuria in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/16406.html" rel="external">"Definition and staging of chronic kidney disease in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7190.html" rel="external">"Chronic kidney disease and coronary heart disease"</a>.)</p><p></p><p class="headingAnchor" id="H1658951563"><span class="h2">Glucose</span><span class="headingEndMark"> — </span>When present in the urine, glucose triggers the production of peroxide, which in turn leads to the oxidation of a chromogen in a reaction catalyzed by peroxidase [<a href="#rid24">24</a>]. As is the case with the dipstick test for heme, ascorbic acid can produce a false-negative test for glycosuria [<a href="#rid31">31</a>]. Glycosuria may be due to either the inability of the kidney to reabsorb filtered glucose in the proximal tubule despite normal plasma glucose concentration or an overflow scenario related to high plasma glucose concentrations overwhelming the capacity of the renal tubules to reabsorb glucose. In patients with normal kidney function, significant glycosuria does not generally occur until the plasma glucose concentration exceeds 180 mg/dL (10 mmol/L).</p><p>When glycosuria occurs with a normal plasma glucose, a primary defect of proximal tubule reabsorption needs to be considered. In this setting, glycosuria may coexist with additional manifestations of proximal tubular dysfunction, including phosphaturia (leading to hypophosphatemia), uricosuria, renal tubular acidosis, and aminoaciduria. This constellation is called the Fanconi syndrome and may result from a variety of disorders, including multiple myeloma, heavy metal exposure, and treatment with certain medications including tenofovir, <a class="drug drug_general" data-topicid="9544" href="/d/drug information/9544.html" rel="external">lamivudine</a>, <a class="drug drug_general" data-topicid="9271" href="/d/drug information/9271.html" rel="external">cisplatin</a>, <a class="drug drug_general" data-topicid="10035" href="/d/drug information/10035.html" rel="external">valproic acid</a>, and aminoglycosides [<a href="#rid40">40</a>]. Glycosuria with normal plasma glucose will also be evident in patients receiving sodium-glucose cotransporter 2 inhibitors.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7210.html" rel="external">"Kidney disease in multiple myeloma and other monoclonal gammopathies: Etiology and evaluation", section on 'Light chain proximal tubulopathy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2328.html" rel="external">"Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/109245.html" rel="external">"Sodium-glucose cotransporter 2 inhibitors for the treatment of hyperglycemia in type 2 diabetes mellitus"</a>.)</p><p></p><p class="headingAnchor" id="H2026353922"><span class="h1">EXAMINATION OF THE URINE SEDIMENT</span><span class="headingEndMark"> — </span>Microscopic examination of the urine sediment may provide valuable data that complement clinical findings, laboratory tests, and urine dipstick results. In the correct clinical context, the presence or absence of certain urinary findings under microscopy may help refine the differential diagnosis. (See <a class="local">'When to examine the urine sediment'</a> above.)</p><p class="headingAnchor" id="H590895435"><span class="h2">Urine sediment technique</span><span class="headingEndMark"> — </span>Ideally 10 to 15 mL of urine is centrifuged for five minutes at 400 x g, which corresponds to &gt;1500 rpm on most commercial centrifuges. Most of the supernatant is then poured out, and the pellet is resuspended with gentle shaking of the tube. A pipette can then be used to place approximately 50 microL (or a small drop) of resuspended sediment on a glass slide, followed by application of a coverslip [<a href="#rid41">41</a>]. An alternative approach is to tilt the test tube and insert the corner of the coverslip into the tube to extrude a single drop of resuspended sediment; the coverslip is then laid onto the slide, thereby allowing a thin film of sediment to become interposed between the coverslip and the slide.</p><p>Brightfield microscopy is generally adequate for review of the urine sediment. Addition of a Sternheimer-Malbin stain to the specimen may enhance the identification of key structures [<a href="#rid1">1</a>]. The light intensity should be subdued because some structures may be missed if the light is excessively bright. As the specimen is reviewed, the fine adjustment on the microscope should be manipulated to appreciate structures in different levels of depth within the sample [<a href="#rid24">24</a>]. The entire specimen is initially scanned at low power using a 10x objective (100x magnification) with particular attention to the edges of the coverslip where casts tend to migrate. High power using a 40x objective (400x magnification) should then be used to better characterize structures that were identified at lower power. Polarized light may be used to search for lipid-laden elements or crystals, as warranted by the clinical context. Phase contrast, if available, may sharpen the definition to structures in the urine sediment.</p><p>The urine sediment examination should be performed by a clinician trained in urine microscopy because the diagnostic yield may be substantially greater compared with a urinalysis performed by laboratory staff [<a href="#rid42">42</a>]. Although automated microscopic platforms have been developed to identify cells and particles in urine, they have not been shown to be as reliable as trained clinicians to diagnosis various kidney diseases such as acute tubular necrosis (ATN), glomerulonephritis, vasculitis, or crystal-induced kidney disease [<a href="#rid42">42-45</a>].</p><p class="headingAnchor" id="H3281506772"><span class="h2">Cells</span><span class="headingEndMark"> — </span>Cellular elements that may be found in the urinary sediment include red blood cells (RBCs), white blood cells (WBCs), and epithelial cells from all levels of the urinary tract.</p><p class="headingAnchor" id="H2522657244"><span class="h3">Red blood cells</span><span class="headingEndMark"> — </span>Hematuria can be benign or reflect serious underlying disease  (<a class="graphic graphic_figure graphicRef61296" href="/d/graphic/61296.html" rel="external">figure 2</a>). The evaluation of patients with hematuria is discussed in detail separately, but some of the major issues will be briefly reviewed here. (See  <a class="medical medical_review" href="/d/html/7208.html" rel="external">"Etiology and evaluation of hematuria in adults"</a>.)</p><p>Hematuria may be grossly visible or microscopic. Microscopic hematuria is commonly defined as the presence of 2 or more RBCs per high-powered field in a spun urine sediment  (<a class="graphic graphic_picture graphicRef80282" href="/d/graphic/80282.html" rel="external">picture 1</a>) [<a href="#rid28">28,46</a>]. The urine color change in gross hematuria does not necessarily reflect a large degree of blood loss, since as little as 1 mL of blood per liter of urine can induce a visible color change. As previously mentioned, red to brown urine can be observed in patients without actual hematuria [<a href="#rid27">27</a>]. (See <a class="local">'Red to brown urine'</a> above.)</p><p>Hematuria may be transient or persistent. Transient hematuria is relatively common and may occur following exercise or sexual intercourse [<a href="#rid28">28</a>]. Menstruation may confound the evaluation of hematuria, and the urinalysis should be repeated when the patient is not menstruating. However, even transient hematuria can represent underlying malignancy, especially in patients over the age of 50 years. Transient hematuria can also occur with urinary tract infection (eg, cystitis or prostatitis). This is typically accompanied by pyuria and bacteriuria, and patients may often complain of dysuria. (See  <a class="medical medical_review" href="/d/html/7208.html" rel="external">"Etiology and evaluation of hematuria in adults"</a>.)</p><p>Persistent hematuria should always be evaluated. Among the more common pathologic causes are kidney stones, malignancy, and glomerular disease. A study of Israeli army recruits showed that, even in asymptomatic individuals, those with isolated persistent hematuria were 18 times more likely to develop end-stage kidney disease (ESKD) over a follow-up period that exceeded 20 years [<a href="#rid47">47</a>]. </p><p>Distinguishing between glomerular and nonglomerular causes is the first key step in the evaluation of unexplained hematuria. Isomorphic RBCs have an appearance similar to erythrocytes in the circulation (small, anucleated cells shaped as biconcave discs) and can be seen with any cause of hematuria. By contrast, dysmorphic RBCs (which have an altered morphology) are suggestive of glomerular disease [<a href="#rid48">48</a>]. There are no uniform criteria for defining dysmorphic RBCs, and designating a certain proportion of RBCs as dysmorphic as the threshold for clinical relevance is debatable; thus, the practical utility of describing dysmorphic RBCs in the diagnosis of glomerular disease has been questioned [<a href="#rid49">49</a>]. However, RBCs that have membrane protrusions (ie, acanthocytes) are a readily definable subset of dysmorphic RBCs  (<a class="graphic graphic_picture graphicRef130438 graphicRef62064" href="/d/graphic/130438.html" rel="external">picture 2A-B</a>) that have a sensitivity of 52 percent and specificity of 98 percent for the diagnosis of glomerulonephritis [<a href="#rid50">50</a>]. The concomitant presence of RBC casts and/or albuminuria in a patient with hematuria increases the likelihood that the observed hematuria is of a glomerular origin [<a href="#rid51">51</a>]. (See  <a class="medical medical_review" href="/d/html/7208.html" rel="external">"Etiology and evaluation of hematuria in adults", section on 'Glomerular versus nonglomerular bleeding'</a> and <a class="local">'Red blood cell casts'</a> below.)</p><p>Less commonly, urinary RBCs with unique morphologies may suggest underlying systemic illness. This includes sickled RBCs in patients with underlying sickle cell trait/anemia and elliptocytes in patients with hemolysis [<a href="#rid52">52</a>]. (See  <a class="medical medical_review" href="/d/html/7119.html" rel="external">"Overview of the clinical manifestations of sickle cell disease"</a> and  <a class="medical medical_review" href="/d/html/7087.html" rel="external">"Hereditary elliptocytosis and related disorders"</a>.)</p><p class="headingAnchor" id="H1565292256"><span class="h3">White blood cells</span><span class="headingEndMark"> — </span>Although the entire spectrum of WBCs may be seen in the urine, neutrophils and eosinophils are the cell types of greatest practical interest to the clinician-microscopist. Neutrophils are intermediate in size compared with RBCs and renal tubular epithelial cells and can be identified by their characteristic granular cytoplasm and multilobed nuclei  (<a class="graphic graphic_picture graphicRef75211" href="/d/graphic/75211.html" rel="external">picture 3</a>). Urinary neutrophils are commonly associated with bacteriuria. However, if the corresponding urine culture is negative (ie, sterile pyuria), interstitial nephritis, renal tuberculosis, and nephrolithiasis should be considered [<a href="#rid53">53</a>]. (See  <a class="medical medical_review" href="/d/html/8056.html" rel="external">"Sampling and evaluation of voided urine in the diagnosis of urinary tract infection in adults"</a> and  <a class="medical medical_review" href="/d/html/7234.html" rel="external">"Clinical manifestations and diagnosis of acute interstitial nephritis", section on 'Clinical features'</a>.)</p><p>Urine eosinophils can be detected by applying Wright or Hansel stain to the urine sediment [<a href="#rid54">54</a>]. The presence of eosinophiluria has traditionally been considered a marker of acute interstitial nephritis. However, in a case series of adults with biopsy-proven acute interstitial nephritis, only 34 percent of patients had eosinophiluria [<a href="#rid55">55</a>]. Thus, testing for eosinophiluria should <strong>not</strong> be used to establish or exclude a diagnosis of acute interstitial nephritis [<a href="#rid56">56,57</a>]. (See  <a class="medical medical_review" href="/d/html/7234.html" rel="external">"Clinical manifestations and diagnosis of acute interstitial nephritis", section on 'Laboratory and radiographic findings'</a>.)</p><p class="headingAnchor" id="H2621941156"><span class="h3">Epithelial cells</span><span class="headingEndMark"> — </span>Epithelial cells may appear in the urine after being shed from anywhere within the genitourinary tract. Renal tubular cells are 1.5 to 3 times larger than white cells and are further distinguished by a round, large, centrally located nucleus  (<a class="graphic graphic_picture graphicRef86348" href="/d/graphic/86348.html" rel="external">picture 4</a>). Transitional epithelial cells originate anywhere from the renal pelvis to the proximal urethra and are slightly larger than renal tubular epithelial cells. They may have a pear-like or oval appearance  (<a class="graphic graphic_picture graphicRef83886" href="/d/graphic/83886.html" rel="external">picture 5</a>). Squamous epithelial cells are derived from the distal urethra or external genitalia. They are large and irregular in shape with a small central nucleus, and their presence represents contamination by genital secretions  (<a class="graphic graphic_picture graphicRef83632" href="/d/graphic/83632.html" rel="external">picture 6</a>).</p><p class="headingAnchor" id="H3658484635"><span class="h2">Casts</span><span class="headingEndMark"> — </span>Casts are cylindrical structures that are formed in the tubular lumen; several factors favor cast formation: urine stasis, low pH, and greater urinary concentration [<a href="#rid24">24</a>]. Casts will assume the shape and size of the renal tubule in which they are formed. All casts have a matrix composed primarily of Tamm-Horsfall mucoprotein (uromodulin), which comprises the basic architecture of any cast. Casts are defined by the nature of the cells or other elements that are embedded in the cast matrix.</p><p class="headingAnchor" id="H1120735474"><span class="h3">Red blood cell casts</span><span class="headingEndMark"> — </span>The finding of RBC casts suggests an underlying proliferative glomerulonephritis, for which numerous etiologies exist  (<a class="graphic graphic_picture graphicRef55778" href="/d/graphic/55778.html" rel="external">picture 2C</a>). However, due to their limited sensitivity, the absence of RBC casts, particularly in a patient with hematuria and a high pre-test probability, does not rule out a proliferative glomerulonephritis [<a href="#rid50">50</a>]. RBC casts are not exclusive to the setting of proliferative glomerulonephritis. In one study, nearly 30 percent of patients with biopsy-proven acute interstitial nephritis had RBC casts in the urine [<a href="#rid58">58</a>]. This implies that RBCs that extrude into the renal tubules from an inflamed interstitium can also lead to cast formation.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7208.html" rel="external">"Etiology and evaluation of hematuria in adults", section on 'Glomerular versus nonglomerular bleeding'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7234.html" rel="external">"Clinical manifestations and diagnosis of acute interstitial nephritis", section on 'Clinical features'</a>.)</p><p></p><p class="headingAnchor" id="H2852441691"><span class="h3">White blood cell casts</span><span class="headingEndMark"> — </span>WBC casts are indicative of interstitial or, less classically, glomerular inflammation  (<a class="graphic graphic_picture graphicRef54319 graphicRef68147" href="/d/graphic/54319.html" rel="external">picture 7A-B</a>). In a biopsy series of patients with confirmed acute interstitial nephritis, only 3 percent of patients had WBC casts in their urine sediment [<a href="#rid55">55</a>]. This highlights that, in the presence of a reasonable clinical suspicion for acute interstitial nephritis, the absence of WBC casts should not diminish consideration of this important diagnosis.</p><p class="headingAnchor" id="H4197555141"><span class="h3">Renal tubular epithelial cell casts</span><span class="headingEndMark"> — </span>These may be observed in any setting where there is desquamation of the tubular epithelium, including ATN, acute interstitial nephritis, and proliferative glomerulonephritis  (<a class="graphic graphic_picture graphicRef65729" href="/d/graphic/65729.html" rel="external">picture 19B</a>).</p><p class="headingAnchor" id="H2136593037"><span class="h3">Granular casts</span><span class="headingEndMark"> — </span>Granular casts represent degenerated cellular casts or the aggregation of proteins within a cast matrix  (<a class="graphic graphic_picture graphicRef59811" href="/d/graphic/59811.html" rel="external">picture 8</a>) [<a href="#rid24">24</a>]. Granular casts may be coarse or fine in nature, although the clinical significance of this distinction is unclear. Coarse, deeply pigmented granular casts (ie, "muddy brown" or heme-granular casts) are considered characteristic of ATN, the leading cause of acute kidney injury (AKI) in hospitalized patients [<a href="#rid59">59</a>].</p><p>In patients with ischemic or toxic injury to the tubular epithelial cells, cell sloughing into the tubular lumen, due either to cell death or to defective cell-to-cell or cell-to-basement membrane adhesion, may lead to the formation of granular and/or epithelial cell casts. (See  <a class="medical medical_review" href="/d/html/7228.html" rel="external">"Pathogenesis and etiology of ischemic acute tubular necrosis", section on 'Epithelial cell injury and dysfunction'</a>.)</p><p class="headingAnchor" id="H1939560079"><span class="h3">Hyaline casts</span><span class="headingEndMark"> — </span>Hyaline casts are only slightly more refractile than water and have a transparent, empty appearance  (<a class="graphic graphic_picture graphicRef86339" href="/d/graphic/86339.html" rel="external">picture 9</a>). Hyaline casts may be observed with small volumes of concentrated urine or diuretic therapy and are generally nonspecific.</p><p class="headingAnchor" id="H924761249"><span class="h3">Waxy casts</span><span class="headingEndMark"> — </span>Waxy casts are thought to be the last stage in the degeneration of a granular cast. They are homogeneous in appearance and are characterized by sharp indentations and darker edges that are more distinct  (<a class="graphic graphic_picture graphicRef83885" href="/d/graphic/83885.html" rel="external">picture 10</a>). Waxy casts are nonspecific and may be observed in a variety of acute and chronic kidney diseases.</p><p class="headingAnchor" id="H4118531542"><span class="h3">Broad casts</span><span class="headingEndMark"> — </span>Broad casts are wider than other casts, a characteristic believed to be due to their formation in large, dilated tubules with little flow  (<a class="graphic graphic_picture graphicRef86555" href="/d/graphic/86555.html" rel="external">picture 11</a>). The presence of broad casts is typically associated with advanced chronic kidney disease (CKD).</p><p class="headingAnchor" id="H3583011146"><span class="h2">Crystals</span><span class="headingEndMark"> — </span>The presence of crystals in the urine depends upon a variety of factors, including the degree of concentration of constituent molecules, the urine pH, and the presence of inhibitors of crystallization. Many different forms may be observed in normal patients and in those with defined disorders  (<a class="graphic graphic_figure graphicRef134707" href="/d/graphic/134707.html" rel="external">figure 3</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Calcium oxalate or calcium phosphate crystals</strong> – Calcium oxalate crystals, which are not dependent upon the urine pH, may appear in the monohydrate form as rods or with a characteristic "dumbbell" appearance or in the dihydrate form as an envelope-like structure  (<a class="graphic graphic_picture graphicRef134705" href="/d/graphic/134705.html" rel="external">picture 12</a> and <a class="graphic graphic_picture graphicRef65169 graphicRef67694" href="/d/graphic/65169.html" rel="external">picture 13A-B</a>).</p><p></p><p class="bulletIndent1">Calcium phosphate crystals form in alkaline urine and have a variety of shapes including prisms that may coalesce into a rosette-like appearance. (See  <a class="medical medical_review" href="/d/html/7375.html" rel="external">"Kidney stones in adults: Epidemiology and risk factors"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Magnesium ammonium phosphate crystals</strong> – Magnesium ammonium phosphate (struvite) and calcium carbonate-apatite are the constituents of struvite stones  (<a class="graphic graphic_picture graphicRef54594" href="/d/graphic/54594.html" rel="external">picture 14</a>). Normal urine is undersaturated with ammonium phosphate. Struvite stone formation occurs only when ammonia production is increased and the urine pH is elevated, which decreases the solubility of phosphate. Both increased ammonia production and increased urine pH occur only in the setting of a urinary tract infection with a urease-producing organism, such as <em>Proteus </em>or <em>Klebsiella</em>. (See  <a class="medical medical_review" href="/d/html/7372.html" rel="external">"Kidney stones in adults: Struvite (infection) stones"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Uric acid crystals</strong> – Uric acid crystals as well as amorphous urates are observed in acidic urine, a milieu that favors the conversion of the relatively soluble urate salt into the insoluble uric acid  (<a class="graphic graphic_picture graphicRef134706" href="/d/graphic/134706.html" rel="external">picture 15</a> and <a class="graphic graphic_picture graphicRef73642" href="/d/graphic/73642.html" rel="external">picture 20B</a>). (See  <a class="medical medical_review" href="/d/html/7379.html" rel="external">"Uric acid kidney diseases"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cystine crystals</strong> – Cystine crystals, with their characteristic hexagonal shape, are diagnostic of cystinuria  (<a class="graphic graphic_picture graphicRef56834" href="/d/graphic/56834.html" rel="external">picture 16</a>). (See  <a class="medical medical_review" href="/d/html/7362.html" rel="external">"Cystinuria and cystine stones"</a>.)  </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other crystals</strong> – The consumption of certain medications may yield urinary crystals. Though some of these medications may cause tubular injury and/or obstruction, the presence of such crystals in the urine does not necessarily imply nephrotoxicity. Commonly used medications with a propensity for crystal formation include <a class="drug drug_general" data-topicid="9335" href="/d/drug information/9335.html" rel="external">acyclovir</a>, sulfonamides, <a class="drug drug_general" data-topicid="9353" href="/d/drug information/9353.html" rel="external">atazanavir</a>, and <a class="drug drug_general" data-topicid="9630" href="/d/drug information/9630.html" rel="external">methotrexate</a>  (<a class="graphic graphic_picture graphicRef132241" href="/d/graphic/132241.html" rel="external">picture 17</a>). (See  <a class="medical medical_review" href="/d/html/7229.html" rel="external">"Crystal-induced acute kidney injury"</a>.)</p><p></p><p>The observation of crystals in the urine is useful in patients with known or suspected kidney stones and is a risk factor for recurrent calcium oxalate [<a href="#rid60">60</a>] or cystine [<a href="#rid61">61</a>] stone formation. In addition, crystalluria may have diagnostic utility in other settings:</p><p class="bulletIndent1"><span class="glyph">●</span>The presence of magnesium ammonium phosphate crystals, which only occur in the setting of an infection with urease-producing bacteria (see  <a class="medical medical_review" href="/d/html/7372.html" rel="external">"Kidney stones in adults: Struvite (infection) stones"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The combination of AKI and calcium oxalate crystals, which may suggest ethylene glycol ingestion (see  <a class="medical medical_review" href="/d/html/336.html" rel="external">"Methanol and ethylene glycol poisoning: Pharmacology, clinical manifestations, and diagnosis", section on 'Clinical features of overdose'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The presence of uric acid crystals occurring in association with AKI, which may suggest tumor lysis syndrome (see  <a class="medical medical_review" href="/d/html/1154.html" rel="external">"Tumor lysis syndrome: Pathogenesis, clinical manifestations, definition, etiology and risk factors"</a> and  <a class="medical medical_review" href="/d/html/1154.html" rel="external">"Tumor lysis syndrome: Pathogenesis, clinical manifestations, definition, etiology and risk factors", section on 'Clinical manifestations'</a>)</p><p></p><p class="headingAnchor" id="H2953120809"><span class="h2">Microorganisms</span><span class="headingEndMark"> — </span>Bacteria are often seen in the urine, although the clinical significance of bacteriuria is generally guided by patient symptoms  (<a class="graphic graphic_picture graphicRef83631" href="/d/graphic/83631.html" rel="external">picture 18</a>). Fungi (yeast) are also frequently present  (<a class="graphic graphic_picture graphicRef83631" href="/d/graphic/83631.html" rel="external">picture 18</a>). (See  <a class="medical medical_review" href="/d/html/8061.html" rel="external">"Asymptomatic bacteriuria in adults"</a>.)</p><p class="headingAnchor" id="H2813506666"><span class="h2">Urinary lipids</span><span class="headingEndMark"> — </span>Lipid droplets, composed primarily of cholesterol esters and, to a lesser degree, cholesterol, are commonly seen on urinalysis in patients with conditions that are associated with the nephrotic syndrome [<a href="#rid62">62,63</a>]. These fat droplets may be free within sloughed tubular cells (called oval fat bodies) or within casts (called fatty casts)  (<a class="graphic graphic_picture graphicRef69603" href="/d/graphic/69603.html" rel="external">picture 2D</a>). Fat droplets have a characteristic "Maltese cross" appearance under polarized light  (<a class="graphic graphic_picture graphicRef79604" href="/d/graphic/79604.html" rel="external">picture 2E</a>).</p><p>Fat droplets are round and may be confused with red cells. They can be differentiated from red cells under routine light microscopy by their variable size (ranging from larger to much smaller than red cells), their dark outline, and the "Maltese cross" appearance under polarized light.</p><p>The origin of urinary lipid is not well understood [<a href="#rid63">63</a>]. The initial step is the filtration of lipoprotein-bound cholesterol, particularly high-density lipoprotein (HDL) cholesterol. Filtration of lipoproteins is minimal in healthy individuals but is markedly enhanced when glomerular permeability to macromolecules is increased in the nephrotic syndrome. Some of the filtered lipoprotein is taken up by the proximal tubular cells. The cholesterol will be seen in the urine sediment as an oval fat body when the cell is desquamated and/or as free droplets or in fatty casts if the lipid is extruded from the cells.</p><p>Because of the apparent requirement for increased glomerular permeability, lipiduria is almost always diagnostic of some form of glomerular disease (see  <a class="medical medical_review" href="/d/html/3041.html" rel="external">"Glomerular disease: Evaluation and differential diagnosis in adults"</a>). One exception is autosomal dominant polycystic kidney disease [<a href="#rid64">64,65</a>]. In one report, urinary oval fat bodies were observed in 21 of 35 patients with autosomal dominant polycystic kidney disease whose average proteinuria on dipstick was only 1+ [<a href="#rid64">64</a>]. Oval fat bodies were also seen in fluid directly aspirated from kidney cysts, and lipid droplets were observed in the epithelial cells lining the cyst wall. Lipiduria may occasionally be seen in other nonglomerular diseases, such as acute or chronic interstitial nephritis or even prerenal azotemia [<a href="#rid65">65</a>].</p><p class="headingAnchor" id="H381067603"><span class="h1">COMMON PATTERNS OF ABNORMAL URINARY FINDINGS</span><span class="headingEndMark"> — </span>Various patterns of urinary findings may suggest specific categories of kidney disease. As with all diagnostic tests, these urinary findings must be interpreted in the context of the history, physical examination, and available laboratory data  (<a class="graphic graphic_table graphicRef56160" href="/d/graphic/56160.html" rel="external">table 1</a>). Patterns of urinary findings and the diagnoses to which they point are discussed below.</p><p class="headingAnchor" id="H1028146572"><span class="h2">Hematuria with dysmorphic RBCs, RBC casts, and proteinuria</span><span class="headingEndMark"> — </span>This constellation of findings (eg, dysmorphic red blood cells [RBCs], RBC casts, and proteinuria) is suggestive of a proliferative glomerular disease, which in the setting of rapidly declining kidney function, constitutes a nephrologic emergency  (<a class="graphic graphic_picture graphicRef130438 graphicRef62064 graphicRef55778 graphicRef69603 graphicRef79604" href="/d/graphic/130438.html" rel="external">picture 2A-E</a>). (See  <a class="medical medical_review" href="/d/html/3041.html" rel="external">"Glomerular disease: Evaluation and differential diagnosis in adults"</a>.)</p><p class="headingAnchor" id="H3487800269"><span class="h2">Heavy proteinuria with absent or minimal hematuria</span><span class="headingEndMark"> — </span>Heavy proteinuria with oval fat bodies, lipid-laden casts, and absent or minimal hematuria is indicative of nonproliferative glomerular diseases including severe diabetic nephropathy. In addition, this pattern may be seen with membranous nephropathy, focal segmental glomerulosclerosis, minimal change disease, and amyloidosis, each of which has both primary and secondary forms. (See  <a class="medical medical_review" href="/d/html/3084.html" rel="external">"Overview of heavy proteinuria and the nephrotic syndrome"</a>.)</p><p class="headingAnchor" id="H278231417"><span class="h2">Granular or epithelial cell casts and renal tubular epithelial cells</span><span class="headingEndMark"> — </span>In a patient with acute kidney injury (AKI), the presence of granular and/or epithelial cell casts with or without free renal tubular epithelial cells is strongly suggestive of acute tubular necrosis (ATN)  (<a class="graphic graphic_picture graphicRef56438 graphicRef65729" href="/d/graphic/56438.html" rel="external">picture 19A-B</a>) [<a href="#rid66">66</a>]. However, a diagnosis of ATN is still possible even if the urinalysis has no granular casts or tubular epithelial cells [<a href="#rid66">66</a>]. The number of observed granular or renal tubular casts may also have prognostic significance; in a study of patients with ATN who were diagnosed based upon clinical criteria, a semiquantitative assessment of the burden of granular or renal tubular epithelial cell casts on low-powered fields was associated with an increased risk of death or the subsequent need for kidney replacement therapy [<a href="#rid67">67</a>].</p><p>The presence of granular casts and tubular epithelial cells in the urine is also associated with progression of AKI in the hospital [<a href="#rid68">68</a>]. Patients whose urinalyses revealed 6 or more granular casts per low-powered field (without tubular epithelial cells), 6 or more tubular epithelial cells per high-powered field (without granular casts), or any number of granular casts and tubular epithelial cells present in the same specimen had a significantly greater likelihood of developing worse kidney function, initiation of dialysis, or death compared with patients who had no granular casts or tubular epithelial cells (54 to 67 percent versus 9 percent). In the setting of unresolving AKI, serial review of the urine sediment may provide novel insights into the patient's diagnosis [<a href="#rid69">69</a>].</p><p class="headingAnchor" id="H2638683254"><span class="h2">Isolated pyuria</span><span class="headingEndMark"> — </span>Isolated pyuria is usually indicative of bacterial urinary tract infection. The differential diagnosis is broad if a concurrent urine culture is negative and includes a partially or recently treated urinary tract infection, non-bacterial infections (including tuberculosis), prostatitis, interstitial nephritis, and nephrolithiasis [<a href="#rid53">53</a>].</p><p class="headingAnchor" id="H4255066121"><span class="h2">Normal or near-normal urinalysis and abnormal kidney function</span><span class="headingEndMark"> — </span>In patients with abnormal kidney function, a relatively normal urinalysis (few cells with little or no proteinuria and no casts other than hyaline casts) is of important diagnostic value and may indicate one of the following conditions:</p><p class="bulletIndent1"><span class="glyph">●</span>Prerenal AKI due to either volume contraction or an effective decrease in circulating volume (eg, heart failure, liver disease)</p><p class="bulletIndent1"><span class="glyph">●</span>Hypercalcemia</p><p class="bulletIndent1"><span class="glyph">●</span>Cast nephropathy in multiple myeloma</p><p class="bulletIndent1"><span class="glyph">●</span>Tumor lysis syndrome</p><p class="bulletIndent1"><span class="glyph">●</span>Acute phosphate nephropathy</p><p class="bulletIndent1"><span class="glyph">●</span>Vascular disease that produces glomerular ischemia but not infarction (eg, hypertensive emergency, scleroderma, thrombotic microangiopathies) or that affects extraglomerular vessels (eg, cholesterol atheroemboli, polyarteritis nodosa)</p><p class="bulletIndent1"><span class="glyph">●</span>Urinary tract obstruction</p><p></p><p class="headingAnchor" id="H107629717"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/15354.html" rel="external">"Patient education: Blood in the urine (hematuria) in adults (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/4412.html" rel="external">"Patient education: Blood in the urine (hematuria) in adults (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/d/html/4425.html" rel="external">"Patient education: Glomerular disease (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H2525275395"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General principles</strong> – In conjunction with the history, physical examination, and laboratory testing, the urinalysis plays a central role in evaluating acute and chronic kidney disease. A complete urinalysis consists of three components: gross evaluation, dipstick analysis, and microscopic examination of the urine sediment. The urine specimen must be properly collected in order to reliably interpret the findings and therefore maximize diagnostic utility. (See <a class="local">'Components of the urinalysis'</a> above and <a class="local">'Indications for testing'</a> above and <a class="local">'Specimen collection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gross assessment</strong> – Normal urine is clear and light yellow in color. Urine turbidity and color may be altered in a number of settings. (See <a class="local">'Gross assessment of the urine'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Urine dipstick analysis</strong> – The urine dipstick provides a rapid semiquantitative assessment of urinary characteristics on a series of test pads embedded on a reagent strip. Most dipsticks permit the analysis of the following core urine parameters: specific gravity, pH, heme, leukocyte esterase, nitrite, albumin, and glucose. (See <a class="local">'Urine dipstick analysis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Examination of the urine sediment</strong> – Microscopic examination of the urine sediment can provide additional diagnostic insights by complementing the clinical data, laboratory tests, and urine dipstick findings. The following diagnostically useful structures may be identified with microscopic examination (see <a class="local">'Examination of the urine sediment'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cells</strong> – Cellular elements that may be found in the urinary sediment include red blood cells (RBCs)  (<a class="graphic graphic_picture graphicRef80282" href="/d/graphic/80282.html" rel="external">picture 1</a>), white blood cells (WBCs)  (<a class="graphic graphic_picture graphicRef75211" href="/d/graphic/75211.html" rel="external">picture 3</a>), and epithelial cells from all levels of the urinary tract  (<a class="graphic graphic_picture graphicRef86348" href="/d/graphic/86348.html" rel="external">picture 4</a> and <a class="graphic graphic_picture graphicRef83886" href="/d/graphic/83886.html" rel="external">picture 5</a> and <a class="graphic graphic_picture graphicRef83632" href="/d/graphic/83632.html" rel="external">picture 6</a>). (See <a class="local">'Cells'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Casts</strong> – Casts are cylindrical structures that are formed in the tubular lumen. They are defined by the nature of the cells or other elements that are embedded in the cell matrix. Casts that can be found in the urinary sediment include RBC casts  (<a class="graphic graphic_picture graphicRef55778" href="/d/graphic/55778.html" rel="external">picture 2C</a>), WBC casts  (<a class="graphic graphic_picture graphicRef54319 graphicRef68147" href="/d/graphic/54319.html" rel="external">picture 7A-B</a>), renal tubular epithelial cell casts  (<a class="graphic graphic_picture graphicRef65729" href="/d/graphic/65729.html" rel="external">picture 19B</a>), granular casts  (<a class="graphic graphic_picture graphicRef59811" href="/d/graphic/59811.html" rel="external">picture 8</a>), and hyaline casts  (<a class="graphic graphic_picture graphicRef86339" href="/d/graphic/86339.html" rel="external">picture 9</a>). (See <a class="local">'Casts'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Crystals</strong> – Crystals in the urine sediment can include calcium phosphate or calcium oxalate crystals  (<a class="graphic graphic_picture graphicRef65169 graphicRef67694" href="/d/graphic/65169.html" rel="external">picture 13A-B</a>), magnesium ammonium phosphate crystals  (<a class="graphic graphic_picture graphicRef54594" href="/d/graphic/54594.html" rel="external">picture 14</a>), uric acid crystals  (<a class="graphic graphic_picture graphicRef61827 graphicRef73642" href="/d/graphic/61827.html" rel="external">picture 20A-B</a>), cystine crystals  (<a class="graphic graphic_picture graphicRef56834" href="/d/graphic/56834.html" rel="external">picture 16</a>), and others. (See <a class="local">'Crystals'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Urinary lipids</strong> – Lipid droplets, composed primarily of cholesterol esters and, to a lesser degree, cholesterol, are commonly seen on urinalysis in patients with conditions that are associated with the nephrotic syndrome. (See <a class="local">'Urinary lipids'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical correlation</strong> – Various patterns of urinary findings may suggest specific categories of kidney disease. As with all diagnostic tests, these urinary findings must be interpreted in the context of the history, physical examination, and available laboratory data  (<a class="graphic graphic_table graphicRef56160" href="/d/graphic/56160.html" rel="external">table 1</a>). (See <a class="local">'Common patterns of abnormal urinary findings'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Rabinovitch A, Arzoumanian L, Curcio KM, et al. Urinalysis-approved guideline, 3rd ed. Clinical and Laboratory Standard Institute, 29(4), 2009 Wayne, PA. http://www.clsi.org/source/orders/free/gp16-a3.pdf (Accessed on March 07, 2012).</li><li class="breakAll">Rose BD. Pathophysiology of Renal Disease, 2nd ed, McGraw-Hill, New York 1987. p.10.</li><li><a class="nounderline abstract_t">Pimstone NR. Renal degradation of hemoglobin. Semin Hematol 1972; 9:31.</a></li><li><a class="nounderline abstract_t">Crane DB, Wheeler WE, Smith MJ. Chyluria. Urology 1977; 9:429.</a></li><li><a class="nounderline abstract_t">Cheng JT, Mohan S, Nasr SH, D'Agati VD. Chyluria presenting as milky urine and nephrotic-range proteinuria. Kidney Int 2006; 70:1518.</a></li><li><a class="nounderline abstract_t">Nates J, Avidan A, Gozal Y, Gertel M. Appearance of white urine during propofol anesthesia. Anesth Analg 1995; 81:210.</a></li><li class="breakAll">Mills F, Jeffrey J, Ayling R. A cause of pink urine. BMJ 2013; 347:f6289. Available at: https://www.bmj.com/content/347/bmj.f6289 (Accessed on June 25, 2021).</li><li><a class="nounderline abstract_t">Stern AB, Stewart HD, Singh HK, Kshirsagar AV. Pink urine after propofol anesthesia. Kidney Int 2010; 78:1193.</a></li><li><a class="nounderline abstract_t">Potton L, Bonadona A, Minet C, Timsit JF. Pink urine. Intensive Care Med 2013; 39:389.</a></li><li><a class="nounderline abstract_t">Stratta P, Barbe MC. Images in clinical medicine. Green urine. N Engl J Med 2008; 358:e12.</a></li><li><a class="nounderline abstract_t">Lepenies J, Toubekis E, Frei U, Schindler R. Green urine after motorcycle accident. Nephrol Dial Transplant 2000; 15:725.</a></li><li><a class="nounderline abstract_t">Blakey SA, Hixson-Wallace JA. Clinical significance of rare and benign side effects: propofol and green urine. Pharmacotherapy 2000; 20:1120.</a></li><li><a class="nounderline abstract_t">Bernante P, Francini F, Zangrandi F, et al. Green urine after intragastric balloon placement for the treatment of morbid obesity. Obes Surg 2003; 13:951.</a></li><li><a class="nounderline abstract_t">Gillett MJ, Burnett JR. Medications and green urine. Intern Med J 2006; 36:64.</a></li><li><a class="nounderline abstract_t">Leclercq P, Loly C, Delanaye P, et al. Green urine. Lancet 2009; 373:1462.</a></li><li><a class="nounderline abstract_t">Raymond JR, Yarger WE. Abnormal urine color: differential diagnosis. South Med J 1988; 81:837.</a></li><li><a class="nounderline abstract_t">Viswanathan S. Urine bag as a modern day matula. ISRN Nephrol 2013; 2013:215690.</a></li><li><a class="nounderline abstract_t">Slotki IN, MacIver JE, Mallick NP, Palmer HM. Acute intravascular hemolysis with minimal renal impairment in Clostridium perfringens infection. Clin Nephrol 1976; 6:451.</a></li><li><a class="nounderline abstract_t">Massoud OI, Yousef WI, Mullen KD. Hemoglobinuria with ribavirin treatment. J Clin Gastroenterol 2003; 36:367.</a></li><li><a class="nounderline abstract_t">Piana S, Longo C. Diffuse Melanosis and Melanuria. N Engl J Med 2019; 380:1166.</a></li><li><a class="nounderline abstract_t">Abubacker NR, Jayaraman SM, R K, et al. Purple Urine Bag Syndrome. J Clin Diagn Res 2015; 9:OD01.</a></li><li><a class="nounderline abstract_t">Plaçais L, Denier C. Purple Urine after Catheterization. N Engl J Med 2019; 381:e33.</a></li><li><a class="nounderline abstract_t">Aklilu AM, Avigan ZM, Brewster UC. A unique case of purple urine: A case report and literature review. Clin Nephrol 2021; 95:273.</a></li><li class="breakAll">Graff L. A Handbook of Routine Urinalysis, Lippincott, Williams and Wilkins, Philadelphia 1983.</li><li><a class="nounderline abstract_t">Fogazzi GB, Verdesca S, Garigali G. Urinalysis: core curriculum 2008. Am J Kidney Dis 2008; 51:1052.</a></li><li><a class="nounderline abstract_t">Mazouz B, Almagor M. False-positive microhematuria in dipsticks urinalysis caused by the presence of semen in urine. Clin Biochem 2003; 36:229.</a></li><li><a class="nounderline abstract_t">Liu JJ, Jones JS, Rao PK. Urinalysis in the Evaluation of Hematuria. JAMA 2016; 315:2726.</a></li><li><a class="nounderline abstract_t">Cohen RA, Brown RS. Clinical practice. Microscopic hematuria. N Engl J Med 2003; 348:2330.</a></li><li><a class="nounderline abstract_t">Daum GS, Krolikowski FJ, Reuter KL, et al. Dipstick evaluation of hematuria in abdominal trauma. Am J Clin Pathol 1988; 89:538.</a></li><li><a class="nounderline abstract_t">Schröder FH. Microscopic haematuria. BMJ 1994; 309:70.</a></li><li><a class="nounderline abstract_t">Brigden ML, Edgell D, McPherson M, et al. High incidence of significant urinary ascorbic acid concentrations in a west coast population--implications for routine urinalysis. Clin Chem 1992; 38:426.</a></li><li><a class="nounderline abstract_t">Nagel D, Seiler D, Hohenberger EF, Ziegler M. Investigations of ascorbic acid interference in urine test strips. Clin Lab 2006; 52:149.</a></li><li><a class="nounderline abstract_t">Nicot GS, Merle LJ, Charmes JP, et al. Transient glomerular proteinuria, enzymuria, and nephrotoxic reaction induced by radiocontrast media. JAMA 1984; 252:2432.</a></li><li><a class="nounderline abstract_t">Cheng KH, Chu CS, Lee KT, et al. Evaluation of microalbuminuria after non-ionic radiocontrast medium exposure in patients undergoing coronary angiography. Int J Cardiol 2008; 127:126.</a></li><li><a class="nounderline abstract_t">Tonelli M, Muntner P, Lloyd A, et al. Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med 2011; 154:12.</a></li><li><a class="nounderline abstract_t">Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375:2073.</a></li><li><a class="nounderline abstract_t">Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011) 2013; 3:19.</a></li><li><a class="nounderline abstract_t">Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011; 305:1553.</a></li><li><a class="nounderline abstract_t">Tangri N, Grams ME, Levey AS, et al. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA 2016; 315:164.</a></li><li><a class="nounderline abstract_t">Haque SK, Ariceta G, Batlle D. Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies. Nephrol Dial Transplant 2012; 27:4273.</a></li><li><a class="nounderline abstract_t">Cavanaugh C, Perazella MA. Urine Sediment Examination in the Diagnosis and Management of Kidney Disease: Core Curriculum 2019. Am J Kidney Dis 2019; 73:258.</a></li><li><a class="nounderline abstract_t">Tsai JJ, Yeun JY, Kumar VA, Don BR. Comparison and interpretation of urinalysis performed by a nephrologist versus a hospital-based clinical laboratory. Am J Kidney Dis 2005; 46:820.</a></li><li><a class="nounderline abstract_t">Bakan E, Ozturk N, Baygutalp NK, et al. Comparison of Cobas 6500 and Iris IQ200 fully-automated urine analyzers to manual urine microscopy. Biochem Med (Zagreb) 2016; 26:365.</a></li><li><a class="nounderline abstract_t">Sharda N, Bakhtar O, Thajudeen B, et al. Manual urine microscopy versus automated urine analyzer microscopy in patients with acute kidney injury. Lab Med 2014; 45:e152.</a></li><li><a class="nounderline abstract_t">Wesarachkitti B, Khejonnit V, Pratumvinit B, et al. Performance Evaluation and Comparison of the Fully Automated Urinalysis Analyzers UX-2000 and Cobas 6500. Lab Med 2016; 47:124.</a></li><li><a class="nounderline abstract_t">Ingelfinger JR. Hematuria in Adults. N Engl J Med 2021; 385:153.</a></li><li><a class="nounderline abstract_t">Vivante A, Afek A, Frenkel-Nir Y, et al. Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA 2011; 306:729.</a></li><li><a class="nounderline abstract_t">Birch DF, Fairley KF. Haematuria: glomerular or non-glomerular? Lancet 1979; 2:845.</a></li><li><a class="nounderline abstract_t">Pollock C, Liu PL, Györy AZ, et al. Dysmorphism of urinary red blood cells--value in diagnosis. Kidney Int 1989; 36:1045.</a></li><li><a class="nounderline abstract_t">Köhler H, Wandel E, Brunck B. Acanthocyturia--a characteristic marker for glomerular bleeding. Kidney Int 1991; 40:115.</a></li><li><a class="nounderline abstract_t">Harel Z, Simel DL, Wald R. Urinalysis in the Evaluation of Proliferative Glomerulonephritis. JAMA 2017; 318:1276.</a></li><li><a class="nounderline abstract_t">Tesser Poloni JA, Bosan IB, Garigali G, Fogazzi GB. Urinary red blood cells: not only glomerular or nonglomerular. Nephron Clin Pract 2012; 120:c36.</a></li><li><a class="nounderline abstract_t">Wise GJ, Schlegel PN. Sterile pyuria. N Engl J Med 2015; 372:1048.</a></li><li><a class="nounderline abstract_t">Nolan CR 3rd, Anger MS, Kelleher SP. Eosinophiluria--a new method of detection and definition of the clinical spectrum. N Engl J Med 1986; 315:1516.</a></li><li><a class="nounderline abstract_t">Muriithi AK, Leung N, Valeri AM, et al. Biopsy-proven acute interstitial nephritis, 1993-2011: a case series. Am J Kidney Dis 2014; 64:558.</a></li><li><a class="nounderline abstract_t">Ruffing KA, Hoppes P, Blend D, et al. Eosinophils in urine revisited. Clin Nephrol 1994; 41:163.</a></li><li><a class="nounderline abstract_t">Muriithi AK, Nasr SH, Leung N. Utility of urine eosinophils in the diagnosis of acute interstitial nephritis. Clin J Am Soc Nephrol 2013; 8:1857.</a></li><li><a class="nounderline abstract_t">Fogazzi GB, Ferrari B, Garigali G, et al. Urinary sediment findings in acute interstitial nephritis. Am J Kidney Dis 2012; 60:330.</a></li><li><a class="nounderline abstract_t">Esson ML, Schrier RW. Diagnosis and treatment of acute tubular necrosis. Ann Intern Med 2002; 137:744.</a></li><li><a class="nounderline abstract_t">Daudon M, Hennequin C, Boujelben G, et al. Serial crystalluria determination and the risk of recurrence in calcium stone formers. Kidney Int 2005; 67:1934.</a></li><li><a class="nounderline abstract_t">Daudon M, Cohen-Solal F, Barbey F, et al. Cystine crystal volume determination: a useful tool in the management of cystinuric patients. Urol Res 2003; 31:207.</a></li><li><a class="nounderline abstract_t">ZIMMER JG, DEWEY R, WATERHOUSE C, TERRY R. The origin and nature of anisotropic urinary lipids in the nephrotic syndrome. Ann Intern Med 1961; 54:205.</a></li><li><a class="nounderline abstract_t">Streather CP, Varghese Z, Moorhead JF, Scoble JE. Lipiduria in renal disease. Am J Hypertens 1993; 6:353S.</a></li><li><a class="nounderline abstract_t">Duncan KA, Cuppage FE, Grantham JJ. Urinary lipid bodies in polycystic kidney disease. Am J Kidney Dis 1985; 5:49.</a></li><li><a class="nounderline abstract_t">Braden GL, Sanchez PG, Fitzgibbons JP, et al. Urinary doubly refractile lipid bodies in nonglomerular renal diseases. Am J Kidney Dis 1988; 11:332.</a></li><li><a class="nounderline abstract_t">Perazella MA, Coca SG, Kanbay M, et al. Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol 2008; 3:1615.</a></li><li><a class="nounderline abstract_t">Chawla LS, Dommu A, Berger A, et al. Urinary sediment cast scoring index for acute kidney injury: a pilot study. Nephron Clin Pract 2008; 110:c145.</a></li><li><a class="nounderline abstract_t">Perazella MA, Coca SG, Hall IE, et al. Urine microscopy is associated with severity and worsening of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol 2010; 5:402.</a></li><li class="breakAll">Varghese V, Soledad River M, Alghamdi AM, et al. Diagnostic utility of serial microscopic examination of the urinary sediment in acute kidney injury. Kidney360 2021; 2:182. Available at: https://kidney360.asnjournals.org/content/2/2/182 (Accessed on June 25, 2021).</li></ol></div><div id="topicVersionRevision">Topic 7196 Version 43.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="http://www.clsi.org/source/orders/free/gp16-a3.pdf" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Rabinovitch A, Arzoumanian L, Curcio KM, et al. Urinalysis-approved guideline, 3rd ed. Clinical and Laboratory Standard Institute, 29(4), 2009 Wayne, PA. http://www.clsi.org/source/orders/free/gp16-a3.pdf (Accessed on March 07, 2012).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Rose BD. Pathophysiology of Renal Disease, 2nd ed, McGraw-Hill, New York 1987. p.10.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4553044" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Renal degradation of hemoglobin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/855068" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Chyluria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16871246" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Chyluria presenting as milky urine and nephrotic-range proteinuria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7598270" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Appearance of white urine during propofol anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7598270" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Appearance of white urine during propofol anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21076457" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Pink urine after propofol anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23389439" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Pink urine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18337597" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Images in clinical medicine. Green urine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10809821" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Green urine after motorcycle accident.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10999506" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Clinical significance of rare and benign side effects: propofol and green urine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14738690" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Green urine after intragastric balloon placement for the treatment of morbid obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16409318" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Medications and green urine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19394536" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Green urine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3393939" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Abnormal urine color: differential diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24959539" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Urine bag as a modern day matula.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/184994" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Acute intravascular hemolysis with minimal renal impairment in Clostridium perfringens infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12642748" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Hemoglobinuria with ribavirin treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30893538" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Diffuse Melanosis and Melanuria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26435987" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Purple Urine Bag Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31665581" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Purple Urine after Catheterization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33605870" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : A unique case of purple urine: A case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33605870" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : A unique case of purple urine: A case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18501787" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Urinalysis: core curriculum 2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12726934" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : False-positive microhematuria in dipsticks urinalysis caused by the presence of semen in urine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27357242" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Urinalysis in the Evaluation of Hematuria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12788998" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Clinical practice. Microscopic hematuria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3354507" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Dipstick evaluation of hematuria in abdominal trauma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8038666" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Microscopic haematuria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1547565" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : High incidence of significant urinary ascorbic acid concentrations in a west coast population--implications for routine urinalysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16584061" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Investigations of ascorbic acid interference in urine test strips.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6148429" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Transient glomerular proteinuria, enzymuria, and nephrotoxic reaction induced by radiocontrast media.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17537532" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Evaluation of microalbuminuria after non-ionic radiocontrast medium exposure in patients undergoing coronary angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21200034" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20483451" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25018975" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Chapter 1: Definition and classification of CKD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21482743" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : A predictive model for progression of chronic kidney disease to kidney failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26757465" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23235953" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30249419" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Urine Sediment Examination in the Diagnosis and Management of Kidney Disease: Core Curriculum 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16253721" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Comparison and interpretation of urinalysis performed by a nephrologist versus a hospital-based clinical laboratory.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27812305" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Comparison of Cobas 6500 and Iris IQ200 fully-automated urine analyzers to manual urine microscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25425026" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Manual urine microscopy versus automated urine analyzer microscopy in patients with acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27069030" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Performance Evaluation and Comparison of the Fully Automated Urinalysis Analyzers UX-2000 and Cobas 6500.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34233098" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Hematuria in Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21846854" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/90933" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Haematuria: glomerular or non-glomerular?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2689749" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Dysmorphism of urinary red blood cells--value in diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1921146" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Acanthocyturia--a characteristic marker for glomerular bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28973230" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Urinalysis in the Evaluation of Proliferative Glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22205019" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Urinary red blood cells: not only glomerular or nonglomerular.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25760357" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Sterile pyuria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2431314" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Eosinophiluria--a new method of detection and definition of the clinical spectrum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24927897" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Biopsy-proven acute interstitial nephritis, 1993-2011: a case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8187360" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Eosinophils in urine revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24052222" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Utility of urine eosinophils in the diagnosis of acute interstitial nephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22677261" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Urinary sediment findings in acute interstitial nephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12416948" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Diagnosis and treatment of acute tubular necrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15840041" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Serial crystalluria determination and the risk of recurrence in calcium stone formers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12748836" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Cystine crystal volume determination: a useful tool in the management of cystinuric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13788521" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : The origin and nature of anisotropic urinary lipids in the nephrotic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8297543" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Lipiduria in renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3966470" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Urinary lipid bodies in polycystic kidney disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3354569" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Urinary doubly refractile lipid bodies in nonglomerular renal diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18784207" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18953176" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Urinary sediment cast scoring index for acute kidney injury: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20089493" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Urine microscopy is associated with severity and worsening of acute kidney injury in hospitalized patients.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
